PLK1 |
PLK1, PLK: Serine/threonine-protein kinase PLK1 |
CDC25C |
CDC25C: M-phase inducer phosphatase 3 |
13.490 |
Evidence |
|
BLM |
BLM, RECQ2, RECQL3: Bloom syndrome protein |
RAD51 |
RAD51, RAD51A, RECA: DNA repair protein RAD51 homolog 1 |
13.490 |
Evidence |
|
SNRPD3 |
SNRPD3: Small nuclear ribonucleoprotein Sm D3 |
DDX20 |
DDX20, DP103, GEMIN3: Probable ATP-dependent RNA helicase DDX20 |
13.490 |
Evidence |
O
|
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
CD2AP |
CD2AP: CD2-associated protein |
13.490 |
Evidence |
O
|
CCNE1 |
CCNE1, CCNE: G1/S-specific cyclin-E1 |
CDC25A |
CDC25A: M-phase inducer phosphatase 1 |
13.490 |
Evidence |
|
RASA1 |
RASA1, RASA: Ras GTPase-activating protein 1 |
DOK1 |
DOK1: Docking protein 1 |
13.490 |
Evidence |
|
HCK |
IPI00029769 |
ELMO1 |
IPI00219532 |
13.490 |
Evidence |
|
GRB2 |
GRB2, ASH: Growth factor receptor-bound protein 2 |
PTPN12 |
PTPN12: Tyrosine-protein phosphatase non-receptor type 12 |
13.490 |
Evidence |
|
SNRPD3 |
SNRPD3: Small nuclear ribonucleoprotein Sm D3 |
GEMIN5 |
GEMIN5: Gem-associated protein 5 |
13.490 |
Evidence |
O
|
KPNA2 |
KPNA2, RCH1, SRP1: Importin subunit alpha-2 |
RELA |
RELA, NFKB3: Transcription factor p65 |
13.450 |
Evidence |
|
CDK4 |
CDK4: Cell division protein kinase 4 |
CDKN1A |
CDKN1A, CAP20, CDKN1, CIP1, MDA6, PIC1, SDI1, WAF1: Cyclin-dependent kinase inhi |
13.360 |
Evidence |
O
|
F2 |
F2: Prothrombin precursor |
GP5 |
GP5: Platelet glycoprotein V precursor |
13.320 |
Evidence |
|
EFNA3 |
EFNA3, EFL2, EPLG3, LERK3: Ephrin-A3 precursor |
EPHA7 |
EPHA7, EHK3, HEK11: Ephrin type-A receptor 7 precursor |
13.270 |
Evidence |
|
EFNB2 |
EFNB2, EPLG5, HTKL, LERK5: Ephrin-B2 precursor |
EPHB6 |
EPHB6: Ephrin type-B receptor 6 precursor |
13.270 |
Evidence |
O
|
STAT6 |
STAT6: Signal transducer and activator of transcription 6 |
RELA |
RELA, NFKB3: Transcription factor p65 |
13.230 |
Evidence |
|
ARHGEF6 |
ARHGEF6, COOL2, KIAA0006, PIXA: Rho guanine nucleotide exchange factor 6 |
SMAD2 |
SMAD2, MADH2, MADR2: Mothers against decapentaplegic homolog 2 |
13.230 |
Evidence |
|
CCND1 |
CCND1, BCL1, PRAD1: G1/S-specific cyclin-D1 |
BRCA1 |
BRCA1, RNF53: Breast cancer type 1 susceptibility protein |
13.2 |
Evidence |
O
|
STAM2 |
STAM2: Signal transducing adapter molecule 2 |
EPS15 |
EPS15, AF1P: Epidermal growth factor receptor substrate 15 |
13.2 |
Evidence |
|
MAPK3 |
MAPK3, ERK1, PRKM3: Mitogen-activated protein kinase 3 |
SYK |
SYK: Tyrosine-protein kinase SYK |
13.2 |
Evidence |
|
DAPP1 |
IPI00004301 |
LYN |
LYN: Tyrosine-protein kinase Lyn |
13.120 |
Evidence |
|
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
DEF6 |
DEF6, IBP: Differentially expressed in FDCP 6 |
13.120 |
Evidence |
|
APOA1 |
APOA1: Apolipoprotein A-I precursor |
TTR |
TTR, PALB: Transthyretin precursor |
13.120 |
Evidence |
|
LAT |
LAT: Linker for activation of T-cells family member 1 |
ZAP70 |
ZAP70: Uncharacterized protein ZAP70 |
13.010 |
Evidence |
|
JUN |
JUN: Transcription factor AP-1 |
MAPK8 |
MAPK8, JNK1, PRKM8: Mitogen-activated protein kinase 8 |
13.010 |
Evidence |
|
LAT |
LAT: Linker for activation of T-cells family member 1 |
LCK |
LCK: Proto-oncogene tyrosine-protein kinase LCK |
13.010 |
Evidence |
|